# Med School researchers develop lupus treatment
## 
### Gina Lee Staff writer 
Researchers at the School of Medicine ap
pear to have developed a revolutionary hor
mone treatment that alleviates symptoms of
the autoimmune disorder lupus erythemato
sus without causing serious side effects.
Dr. Ronald van Vollenhoven, a clinical
instructor in the Department of Medicine,
presented the preliminary results of the
lupus treatment last week at a meeting of
the American College of Rheumatology in
San Antonio, Texas.
"The reaction of the audience, many of
them lupus experts, was encouraging and
we plan to continue research on the treat
ment," van Vollenhoven said.

During the three-month preliminary
study, sponsored by the Northern Califor
nia Arthritis Foundation and the Bay Area
Lupus Foundation, researchers produced
capsules containing high levels of the hor
mone, dehydroepiandrosterone, or DHEA,
that were taken by 30 infected patients.
This hormone is normally produced by a
healthy person's adrenal glands.
"We know that many people with lupus
have unusually low levels of this hormone, so
we thought that boosting the levels of the hor
mone might alleviate some of the symptoms
of the disease," van Vollenhoven said.
Common lupus symptoms â€” including
breathing difficulty, fever, joint pain and
